MetaXearch > / Biotechnology and Pharmaceuticals / Pharmaceuticals / Biopharmaceuticals / Research and Development /
Aphton Corp.
Develops products using vaccine-like technology for neutralizing hormones which participate in gastrointestinal system and reproductive system cancer and non-cancer diseases and the prevention of pregnancy. Based in Miami, Florida. (Nasdaq: APHT) (infos)Archemix Corp.
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts. (infos)
Arena Pharmaceuticals, Inc.
Receptor-based drug discovery in the fields of diabetes, obesity, cardiovascular, sleep disorders, neurodegeneration, schizophrenia, depression and anxiety. Comprehensive profile of company in San Diego, California. (Nasdaq: ARNA) (infos)
AusAm Biotechnologies, Inc.
Developing diagnostics and drugs from core discoveries in protein and polysaccharide chemistry, including anti-viral attachment inhibitors. Includes research overview, distributors, and offices in Chicago and Santa Monica, California. (infos)
AVI Biopharma, Inc.
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII) (infos)
Avigen, Inc.
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN) (infos)
BioMep Inc.
Company founded in 1997 to develop new therapies for bone diseases. Outlines products under development and news from Montreal, Canada. (infos)
EntreMed, Inc.
Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD) (infos)
BioSphings AG.
Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany. (infos)
Cue Biotech Inc.
Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with media resources, list of publications, and opportunities in Chicago, Illinois. (infos)